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Insular Cortex Lesions and Morphine-Induced Suppression of CS
Intake in the Rat
Christopher Roman and Steve Reilly
Department of Psychology, University of Illinois at Chicago
Abstract
The present experiment examined the influence of insular cortex (IC) lesions on the intake of a taste
stimulus in a consummatory procedure that used morphine as the unconditioned stimulus. In normal
rats, morphine caused a rapid reduction in saccharin intake when the taste was novel but not when
it was familiar. Irrespective of stimulus novelty, morphine had little influence on the saccharin
consumption of IC-lesioned rats. The results are discussed in terms of a lesion-induced disruption of
(i) a reward comparison mechanism and (ii) the perception of taste novelty.
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A number of lesion-behavior studies have implicated the insular cortex (IC) in the acquisition
of conditioned taste aversions (CTAs; e.g., Bermudez-Rattoni & McGaugh, 1991; Braun, Slick,
& Lorden, 1972; Cubero, Thiele, & Bernstein, 1999; Fresquet, Angst, & Sandner, 2004; Gallo,
Roldan, & Bures, 1992; Nerad, Ramirez-Amaya, Ormsby & Bermudez-Rattoni, 1996).
However, since these studies employed a procedure with a single pairing of the taste
conditioned stimulus (CS) and the lithium chloride (LiCl) unconditioned stimulus (US), it is
difficult to determine whether IC lesions attenuate or abolish CTA acquisition. Recent work
in our laboratory, using a multiple conditioning trial design, found that IC-lesioned (ICX) rats
are capable of acquiring a CTA but that they do so at a slower rate than neurologically intact
subjects (Roman, Nebieridze, Sastre, & Reilly, 2006). The attenuation of CTA acquisition
seems best attributed to an inability on the part of ICX rats to accurately recognize the novelty
of the unfamiliar taste stimulus rather than of an associative deficit or a disruption in the
processing of the toxic US. A failure to detect taste novelty (and thereby to mistakenly treat
the taste CS as if it were familiar) would be expected to attenuate CTA acquisition because of
a latent inhibition-like effect. Consistent with this analysis, IC lesions disrupt CTA acquisition
when the taste CS is novel but not when the taste CS is familiar (Kiefer & Braun, 1977; Roman
& Reilly, 2007).
Suppression of CS intake can be induced with a wide variety of USs, ranging from toxins (e.g.,
LiCl) to X-rays to drugs of abuse (see, for example, Gamzu, Vincent Boff, 1985; Riley & Tuck,
1985). Psychoactive drugs have received a great deal of attention in recent years because of
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the problem of drug addiction, and this has extended into the realm of CTA research. To our
knowledge, only two studies have examined the influence of IC lesions on CTAs induced with
a psychoactive drug (Mackey, Keller & van der Kooy, 1986; Zito, Bechera, Greenwood & van
der Kooy, 1988). Although both studies found that IC lesions disrupted morphine-induced
CTAs (assessed with a two-bottle, saccharin vs. water, test trial), it is difficult to determine the
nature of the deficit because data from the conditioning trials was not included in the reports.
However, since the ICX rats in each study showed normal acquisition of a morphine-induced
conditioned place preference, it seems highly unlikely that the CTA deficit can be attributed
to a lesion-induced disruption in the processing of the morphine drug state.
Deficits in morphine-induced CS suppression have also been reported in rats with lesions of
the gustatory thalamus (GT; Grigson, Lyuboslavsky, & Tanase, 2000; Reilly & Trifunovic,
1999a). The GT is connected reciprocally with the IC (Cechetto & Saper, 1987; Kosar, Grill,
& Norgren, 1986; Norgren & Wolf, 1975; Wolf, 1968), and there is therefore reason to
anticipate a similar deficit consequent to lesions of the IC. To afford comparability with the
aforementioned studies that examined GT-lesioned (GTX) rats in morphine-induced CS
suppression, the design of the present experiment utilized a 5 min CS access period during
each conditioning trial. This is a departure from CTA studies, which typically permit 15 or
more min CS access. The use of a shorter CS access period derives from Grigson’s (1997)
analysis that drug-induced CS suppression is analogous to a consummatory contrast effect in
which ingestion of a relatively low-value reward (e.g., saccharin) is suppressed in anticipation
of a more highly valued reward (e.g., sucrose; for a review of the consummatory contrast
literature see Flaherty, 1996). Evidence is accumulating in supports of the interpretation that
psychoactive drug-induced CS suppression is the result of a comparison of the relative reward
values of the CS and the US drug (for a review see Grigson, Twining, Freet, Wheeler, & Geddes,
2009). According to this “reward comparison hypothesis,” the positive attributes of a CS are
greatly exceeded by the pleasurable properties of the US drug state (as with sucrose in the
traditional paradigm) and so consumption of the CS is reduced. By Grigson’s analysis, then,
self-administered drugs of abuse support taste CS suppression because of their high reward
value not because of their supposed aversive properties.
The experimental design included both acquisition and reversal trials. During acquisition rats
were injected with either the morphine US or the saline vehicle following the saccharin CS. In
reversal, the contingencies were switched such that the rats given the morphine US during
acquisition were injected with saline and vice versa. The results obtained from the reversal
trials are informative for at least two reasons. First, the non-reinforced trials permit an
examination of extinction performance following the taste-drug pairings. Second, data from
the rats that receive morphine during reversal training allows some evaluation of the effect of
prior non-reinforced exposure of the taste CS on later CS-US learning. This effect has not, to
our knowledge, been investigated in this paradigm.
Method
Subjects
Forty-two male CD-IGS rats purchased from Charles River Laboratories (Portage, MI) were
used in these experiments. All rats were individually housed in hanging stainless steel cages
in a room maintained on a 12-hour light/dark cycle; ad libitum food and water were available
except where noted otherwise. The animals weighed ~300 g at the time of surgery, and were
treated according to the guidelines recommended by the National Institutes of Health, the
American Psychological Association, and the Institutional Animal Care and Use Committee
at the University of Illinois at Chicago.
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Rats were anesthetized using sodium pentobarbital at 50 mg/kg, IP. Once unconscious, each
rat received one of three surgical treatments: bilateral N-Methyl-D-aspartic acid (NMDA)
lesions of the IC (Group ICX), ICX surgery without the NMDA infusion, or placement in the
stereotaxic instrument and no subsequent surgery. Rats in the latter two treatment conditions
served as control subjects (Group SHAM).
Surgery began by fixing the rat in a stereotaxic apparatus (ASI; Warren, MI) with nontraumatic
ear bars, shaving the scalp, and applying a 10% iodine antiseptic to the surgical site. Body
temperature was monitored and maintained at 37°C using a rectal probe and heating pad
(Harvard Apparatus, Holliston, MA). An anteroposterior incision was then made along the
midline of the head, and the skin and membrane retracted to expose the skull. The head was
leveled between bregma and lambda, and trephine holes drilled in the skull above the surgical
sites. For rats in the ICX group, glass capillary pipettes (tip ~75 µm diameter) were backfilled
with 0.15 M NMDA (Sigma, St. Louis, MO) and lowered into two infusion sites: site 1, AP
+1.2 mm, ML ±5.2 mm, DV − 5.0 mm; site 2, AP +1.2 mm, ML ±5.2 mm, DV −4.3 mm. The
NMDA was then iontophoretically infused into these target locations with a Midgard precision
current source (Stoelting, Wood Dale, IL) using a current of −10 µA for 10 min at site 1 and
6 min at site 2. The infusions were repeated in the other hemisphere, and then the incision was
closed with wound clips and the rat placed under a heat source until recovered from the
anesthesia. The rat was then returned to its home cage and allowed to recover for at least 7
days before behavioral experimentation began.
Apparatus
All behavioral testing was conducted in the rats’ home cages. While on water restriction, the
rats were given fluids from an inverted 100 ml Nalgene graduated cylinder attached to the front
of the cage, with a stainless steel spout and silicone stopper. Fluid intake from these bottles
was recorded to the nearest 0.5 ml.
Procedure
Following recovery from surgery, all rats were put on a deprivation schedule allowing 5 min
access to water in the morning, and 60 min access 5 hours later in the afternoon. Once water
intake on this schedule stabilized, the rats were divided into four groups according to their
surgical condition (SHAM or ICX) and whether they were to receive injections of physiological
saline (S) or 15 mg/kg morphine sulfate (M; Henry Schein, Indianapolis, IN) during acquisition
and reversal. The groups were thus: SHAM-SM, SHAM-MS, ICX-SM, and ICX-MS.
On the morning after these groups were assigned, all rats received 5 min access to a 0.15% (w/
v) sodium saccharin solution instead of water. The saccharin exposure was followed 5 min
later by an IP injection of either saline or morphine depending upon group assignment. This
was repeated on alternating days for 7 trials, with the usual 5 min morning water sessions on
intervening days. After the seventh conditioning trial, the contingencies were reversed so that
the rats that had been receiving morphine were given saline, and vice versa. This reversal
training continued for a total of 9 trials. The 60 min afternoon water sessions took place every
day regardless of earlier treatments.
Histology
After the behavioral testing was completed, the rats were deeply anesthetized with sodium
pentobarbital (100 mg/ml) and perfused transcardially with physiological saline and 4%
buffered formalin. The brains were extracted and stored in 4% buffered formalin followed by
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20% sucrose for at least 2 days each. The brains were frozen and sliced in a cryostat at 50 µm,
stained with cresyl violet, and evaluated under a light microscope.
Results
Anatomical
The gustatory region of the IC as described by Kosar and colleagues (1986), extends for about
1.0 mm both anterior and posterior to the point of intersection between the rhinal fissure and
the middle cerebral artery (i.e., approximately +0.8 mm relative to bregma; Paxinos & Watson,
2005). The ICX subjects that remained in the final analysis had damage to the majority of this
tissue from ~0.0 mm (bregma) to 2.2 mm anterior to bregma. Figure 1A shows serial
reconstructions of the largest and smallest lesions included in the final results. A representative
photomicrograph of a neurologically intact IC is shown in Figure 1B and an IC lesion can be
seen in Figure 1C. Rats with IC lesions that were either subtotal (n = 4) or unilateral (n = 1)
were dropped from the study. Additionally, two rats (1 SHAM and 1 ICX) became ill and were
unable to complete the experiment; their data were also excluded from the final analyses. The
final number of subjects in each group was: 9 SHAM-SM, 10 SHAM-MS, 8 ICX-SM, and 8
ICX-MS.
Behavioral
Analysis of data from the surgical and non-surgical control rats found no significant behavioral
differences (Fs < 1). Therefore, in all subsequent analyses data from these two groups were
collapsed into a single control group, Group SHAM.
Before the first conditioning trial, average consumption was calculated for each group across
the three most recent 5-min water trials, with the following results (mean ±SE): SHAM-SM =
10.70 ±0.50 ml; SHAM-MS = 10.47 ±0.65 ml; ICX-SM = 10.08 ±0.57 ml; ICX-MS = 9.83
±0.72 ml. An analysis of variance (ANOVA) was conducted on the data from which these
means were derived and found no significant main effect of Lesion (SHAM vs. ICX; p > .30)
or of Condition (S vs. M, a pseudofactor at this point; F < 1), and no Lesion X Condition
interaction (F < 1). Thus, IC lesions had no influence on water intake prior to the start of the
experiment.
Saccharin consumption data during acquisition and reversal are shown in Figure 2. Inspection
of the acquisition phase of the graph shows that SHAM-MS rats quickly decreased saccharin
intake relative to the saline injected SHAM subjects whereas the morphine-treated ICX rats
showed no such effect relative to the ICX control group. An ANOVA performed on the
acquisition data found significant main effects of Lesion, F(1, 31) = 5.37, p < .05, Condition,
F(1, 31) = 14.68, p < .05, and Trials, F(6, 186) = 2.97, p < .05. These main effects were the
result of ICX rats consuming more saccharin overall than SHAM subjects, saline rats drinking
more than morphine subjects, and total consumption decreasing across trials, respectively. The
same ANOVA also revealed a Lesion X Condition X Trials interaction, F(6,186) = 2.19, p < .
05, with SHAM-MS subjects drinking less saccharin across trials compared to the other three
groups, which separate ANOVAs found did not differ from each other (Fs < 1).
Comparisons between SHAM groups across acquisition trials revealed that there was no
significant intake difference on the first trial (p > .05) but morphine injected SHAM rats
consumed significantly less saccharin on trials 2–7 than the saline-injected SHAM subjects
(ps < .001). In summary, there were no differences between SHAM-SM, ICX-SM, and ICX-
MS groups during acquisition, while SHAM-MS rats drank significantly less than their
counterparts in the other three groups. These data indicate that morphine induced saccharin
suppression in SHAM, but not ICX, subjects during the seven acquisition trials.
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After the contingencies were switched during reversal training (trials 8–16), it is clear that
group SHAM-MS increased consumption of the saccharin CS after it was no longer followed
by morphine (see Figure 2). In addition, SHAM-SM subjects showed little suppression during
CS-drug pairings. As in the acquisition phase of this experiment, neither group of ICX rats
decreased saccharin intake. An ANOVA conducted on the data from the nine reversal trials
found a significant Lesion X Condition X Trials interaction, F(8, 248) = 2.15, p < .05. To
follow up this interaction, we conducted two sets of analyses: one comparing data between
SHAM groups on each trial, and the other between the ICX groups. Despite the increase in
consumption by group SHAM-MS during reversal, those subjects drank significantly less
saccharin than their SHAM-SM counterparts on all nine reversal trials (ps < .05). Extinction
of the suppression learned during acquisition did occur in SHAM-MS rats, as they drank more
saccharin on the final reversal trial than they did on the first, F(1, 248) = 23.73, p < .001. While
SHAM-MS animals drank more saccharin in the later trials, reflecting the extinction of the
morphine conditioning, SHAM-SM rats showed a small (less than 2 ml), but significant,
amount of suppression between the first and final reversal trial, F(1, 248) = 6.81, p < .05. It is
worth noting, however, that the amount consumed on the final reversal trial by the SHAM-SM
rats (9.22 ±0.58 ml) is essentially identical to the amount consumed on the first acquisition
trial (9.28 ±0.66 ml). The two ICX groups only differed from each other on reversal trials 8
and 11, with ICX-SM animals consuming more saccharin on the trial 8, F(1, 248) = 4.22, p < .
05, and ICX-MS rats drinking more on trial 11, F(1, 248) = 4.98, p < .05. The overall pattern
of results in the reversal phase show that SHAM-MS rats increased saccharin intake, and that
the SHAM-SM rats showed a small amount of saccharin suppression to a level equivalent to
their initial intake on trial 1 of the experiment. Finally, there is no indication that ICX rats
learned any information about the relationship between saccharin and morphine in this
experiment.
Discussion
In the acquisition phase of the experiment, SHAM-MS animals quickly (i.e., after a single CS-
US pairing) learned to suppress consumption of saccharin when it was followed by morphine,
a finding that is consistent with previous results using experimentally naïve rats (e.g., Grigson,
1997, Experiment 3; Grigson et al., 2000; Experiment 1). Unlike their SHAM counterparts,
ICX-MS rats did not decrease their consumption of the saccharin solution, even after repeated
pairings with the morphine US. Thus, the acquisition data indicate that IC lesions have a
profound influence on morphine-induced suppression of saccharin intake. The behavioral
deficit in ICX rats mirrors the effect of GT lesions in this paradigm (Grigson et al., 2000; Reilly
& Trifunovic, 1999a). It might be noted that GTX rats also fail to acquire sucrose-induced
suppression of a saccharin CS in the anticipatory negative contrast paradigm (Reilly,
Bornovalova & Trifunovic, 2004; Reilly & Pritchard, 1996; Schroy, Wheeler, Davidson,
Scalera, Twining & Grigson, 2005) as well as successive negative contrast in which a low-
value reward (i.e., saccharin) is substituted for an expected high-value reward (i.e., sucrose;
Reilly & Trifunovic, 1999b, 2003). The performance of GTX animals in these tasks has been
interpreted as a lesion-induced impairment of the reward comparison mechanism that governs
the ability to accurately compare the reward values of appetitive stimuli across sessions (e.g.,
Reilly 2005a, 2005b). In other words, GTX rats respond based upon the absolute value of
appetitive stimuli rather than the reward value relative to each other. Since morphine treated
ICX rats failed to decrease saccharin intake in the present experiment, the explanation
forwarded for the behavior of GTX rats may also be applicable to ICX rats. Indeed, as noted
in the Introduction, the GT is reciprocally connected with the IC and similar behavioral deficits
suggest that these two structures serve an inter-dependent function in the brain circuit
underlying reward comparison.
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There are, however, reasons to question whether this analysis is complete with regard to the
role of the IC in morphine-induced suppression of saccharin intake. We have recently obtained
evidence that IC lesions disrupt the initial neophobic response to a novel taste (but not to a
novel aqueous odor or a novel trigeminal stimulus; Lin, Roman, St. Andre & Reilly, under
review). These findings suggest that ICX rats may fail to recognize the novelty of taste stimuli
or perhaps IC lesions disrupt the fear response that is triggered by the detection of a novel taste.
ICX rats also show impaired CTA acquisition when the taste CS is novel but not when it is
familiar in a latent inhibition procedure (Roman & Reilly, 2007). This pattern of impaired and
spared functions encourages the view that IC lesions disrupt the perception of taste novelty. If
familiarity with the taste CS delays the suppression of saccharin (as seen in the SHAM subjects
switched from saline injections in acquisition to the morphine US during the reversal phase of
the present experiment), and ICX subjects respond to the novel CS as if it was familiar, then
the failure of the lesioned rats to decrease saccharin intake across trials may represent a latent
inhibition-like retardation of learning.
There are, then, two plausible explanations for the failure of morphine to suppress saccharin
intake in rats with IC lesions. It is possible, of course, that both types of deficit (reward
comparison and novelty perception) contribute to the abnormal performance of the ICX rats
in the present experiment. However, if IC lesions disrupt incentive learning in the same all-or-
none manner that appears to be the case with GT lesions (Grigson et al., 2000; Reilly &
Trifunovic, 1999a), then one would predict that ICX rats, with or without prior experience of
the taste cue, would never learn to suppress saccharin intake. On the other hand, if IC lesions
disrupt the perception of taste novelty, then ICX rats should, eventually, learn to suppress intake
of both a novel and a familiar CS given sufficient saccharin-morphine conditioning trials as
occurs in latent inhibition studies involving saccharin-LiCl pairings (e.g., Roman & Reilly,
2007).
Overall, the pattern of results obtained from the present experiments revealed two important
new findings regarding morphine-induced CS suppression. First, over 7 acquisition trials, IC
lesions prevented the acquisition of saccharin suppression induced by morphine, an effect that
is readily acquired by normal animals. Second, neurologically intact rats failed to learn to
suppress the same saccharin solution if they have prior nonreinforced exposure to saccharin
(i.e., latent inhibition seems to occur in the CS-drug paradigm). Together these first two
findings encourage the view that IC lesions disrupt a reward comparison mechanism and/or
the perception of taste novelty.
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Serial reconstructions (Panel A) of the smallest (black) and largest (gray) lesions of the insular
cortex at five coronal levels (+2.28, +1.80, +1.20, +0.60, 0.00 relative to bregma).
Representative digital photomicrographs of a cresyl violet-stained coronal section
(approximately +1.0 mm relative to bregma) through the insular cortex of a neurologically
intact subject (Panel B) and a rat with a neurotoxic lesion (Panel C). The extent of cell loss is
outlined with a dashed line. CPu = caudate putamen; rf = rhinal fissure; S2 = secondary
somatosensory cortex. The diagrams in Panel A are adapted with permission from (Paxinos
and Watson 2005).
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Mean (±SE) saccharin intake (ml) across 7 acquisition trials and 9 reversal trials in normal
(SHAM; Panel A) subjects and rats with neurotoxic lesions of the insular cortex (ICX; Panel
B) that were injected with saline during acquisition and morphine during reversal (SM) or vice
versa (MS).
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